Drug shows promise against parasitic disease afflicting millions of African children

A new study in Ethiopia demonstrates that praziquantel—an inexpensive, widely available drug—effectively prevents and treats schistosomiasis in school children. The finding matters for global health programs and pharmaceutical companies: it validates a low-cost intervention that could expand access to treatment across Sub-Saharan Africa, where the parasitic infection affects over 90 million people.

Originaltitel: Efficacy and safety of praziquantel preventive chemotherapy in <i>Schistosoma mansoni</i> infected school children in Southern Ethiopia: A prospective cohort study